Research Paper Volume 13, Issue 23 pp 25089—25105
The isoflavone puerarin exerts anti-tumor activity in pancreatic ductal adenocarcinoma by suppressing mTOR-mediated glucose metabolism
Figure 8. Puerarin suppresses oncogenesis and progression of PDAC via suppressing Akt/mTOR activity.